Feedback / Questions
lirentelimab subcutaneous (AK002 SC) - Allakos
http://clinicaltrials.gov/ct2/show/NCT05155085
Jun 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next